Skip to content

Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice

Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice, 7 Times Per Week for 2 Weeks.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03604081
Enrollment
0
Registered
2018-07-27
Start date
2018-06-11
Completion date
2020-08-14
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Constraint Induced Movement Therapy

Brief summary

This is a prospective randomized control trial of patients with unilateral impairment of the lower extremity after stroke. Patients will be randomized to intervention group and control group. Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice. Control group will receive conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline.

Interventions

OTHERCIMT

Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice.

OTHERConventional Physical Therapy

1 hour as per current standard of care that follows stroke clinical practice guideline.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 55 or older * new ischemic stroke as revealed by CT scan or MRI of a brain or as per updated definition by American heart and American stroke association (Sacco et al., 2013) * Manual muscle testing with grad of \> 1+ in hip and knee joint musculature * able to walk atleast 10 feet indoors with or without assistance and assistive device. * Motivated to participate and some initiation of flexion and extension movement in hip, knee and ankle joints. * Ability to follow visual/verbal instructions as assessed by a minimum score of 24/30 points on the minimental state examination * Fairly intact sensation

Exclusion criteria

* Serious cardiac or pulmonary condition or other medical condition that make it difficult or risky to participate in intensive training * Severe joint pain or degenerative disease to the musculoskeletal system of the lower extremity * other neurological disease 4) problems with following instructions.

Design outcomes

Primary

MeasureTime frameDescription
Cycle time as measured by GAITRite.2 WeeksGAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
step length as measured by GAITRite.2 WeeksGAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
Stride length as measured by GAITRite.2 WeeksGAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
velocity as measured by GAITRite2 WeeksGAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026